{"id":22969,"date":"2026-09-30T08:48:22","date_gmt":"2026-09-30T06:48:22","guid":{"rendered":"https:\/\/mic-site.labiux.com\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/"},"modified":"2026-09-30T08:48:22","modified_gmt":"2026-09-30T06:48:22","slug":"nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/","title":{"rendered":"NVD no oktobra papla\u0161in\u0101s kompens\u0113jamo z\u0101\u013cu pieejam\u012bbu vair\u0101ku slim\u012bbu pacientiem"},"content":{"rendered":"<div class=\"wp-block-labiux-legacy-html legacy-content\">\n<p>No 1. oktobra papla\u0161in\u0101s vair\u0101ku medikamentu kompens\u0101cijas nosac\u012bjumus, tostarp solido audz\u0113ju, spin\u0101l\u0101s musku\u013cu atrofijas un iekais\u012bgu zarnu slim\u012bbu \u0101rst\u0113\u0161anai, otrdien Saeimas Sabiedr\u012bbas vesel\u012bbas apak\u0161komisijas s\u0113d\u0113 inform\u0113ja Nacion\u0101l\u0101 vesel\u012bbas dienesta (NVD) Z\u0101\u013cu un medic\u012bnisko ier\u012b\u010du departamenta direktora vietniece <strong>Zinta Rug\u0101ja<\/strong>.<\/p>\n<p>Pacientu organiz\u0101ciju p\u0101rst\u0101vji vienlaikus uzsv\u0113ra, ka daudzas nepiecie\u0161am\u0101s z\u0101les joproj\u0101m nav pieejamas un uzlabojumiem vajadz\u012bgs liel\u0101ks finans\u0113jums.<\/p>\n<p>No 1. oktobra kapecitab\u012bnu kompens\u0113s visu lokaliz\u0101ciju solido audz\u0113ju gad\u012bjum\u0101, bet spin\u0101l\u0101s musku\u013cu atrofijas terapija b\u016bs pieejama ar\u012b pieaugu\u0161ajiem. Pacientiem ar vid\u0113ji smagu vai smagu Krona slim\u012bbu vai \u010d\u016blaino kol\u012btu adalimumabs b\u016bs pieejams k\u0101 pirm\u0101s izv\u0113les biolo\u0123isk\u0101 terapija. \u0160\u012b medikamenta lieto\u0161ana paredz\u0113ta ar\u012b sarkoidozes gad\u012bjum\u0101. Prezent\u0101cij\u0101 min\u0113ta ar\u012b stomas pre\u010du atreferenc\u0113\u0161ana.<\/p>\n<p>No oktobra \u0123imenes \u0101rsti var\u0113s s\u0101kt terapiju demences gad\u012bjum\u0101. Vi\u0146u loma terapijas s\u0101k\u0161an\u0101 papla\u0161in\u0101ta ar\u012b priek\u0161kambaru mirdz\u0113\u0161anas un pland\u012b\u0161an\u0101s \u0101rst\u0113\u0161an\u0101 ar tr\u012bs jaun\u0101s paaudzes iek\u0161\u0137\u012bgi lietojamiem antikoagulantiem, k\u0101 ar\u012b cukura diab\u0113ta \u0101rst\u0113\u0161an\u0101 ar GLP-1 receptoru agonistiem. Rug\u0101ja skaidroja, ka tas \u013caus \u0101tr\u0101k s\u0101kt \u0101rst\u0113\u0161anu un mazin\u0101s nepiecie\u0161am\u012bbu apmekl\u0113t speci\u0101listu tikai z\u0101\u013cu noz\u012bm\u0113\u0161anai.<\/p>\n<p>NVD inform\u0113ja, ka l\u012bdz 1. oktobrim kompens\u0113jamo z\u0101\u013cu sarakst\u0101 iek\u013cautas 12 jaunas z\u0101\u013cu molekulas un medic\u012bnisk\u0101s ier\u012bces. Jaunas \u0101rst\u0113\u0161anas iesp\u0113jas paredz\u0113tas pacientiem ar limfoleikozi, cistisko fibrozi un hronisku C v\u012brushepat\u012btu, k\u0101 ar\u012b b\u0113rniem ar neiroblastomu, Alad\u017eila sindromu, neirofibromatozi un epilepsiju. Kardiolo\u0123ij\u0101 iek\u013cautas jaunas fiks\u0113tu devu z\u0101\u013cu kombin\u0101cijas.<\/p>\n<p>Rug\u0101ja skaidroja, ka neirofibromatozes \u0101rst\u0113\u0161anai paredz\u0113t\u0101s z\u0101les l\u012bdz \u0161im pacientiem augst\u0101 l\u012bdzmaks\u0101juma d\u0113\u013c bija gr\u016bt\u012bbas ieg\u0101d\u0101ties. Savuk\u0101rt jaunais medikaments cistisk\u0101s fibrozes \u0101rst\u0113\u0161anai pal\u012bdz\u0113s ar\u012b pacientiem ar specifisku mut\u0101ciju, kuriem l\u012bdz\u0161in\u0113j\u0101s z\u0101les neder\u0113ja.<\/p>\n<p>Papla\u0161in\u0101ta ar\u012b glikozes monitor\u0113\u0161anas sist\u0113mu pieejam\u012bba gr\u016btniec\u0113m, kuras lieto insul\u012bnu, pacientiem ar transplant\u0113tu solido org\u0101nu un pacientiem p\u0113c aizku\u0146\u0123a dziedzera rezekcijas.<\/p>\n<p>Dienests p\u0101rskat\u012bjis ar\u012b kompens\u0101cijas nosac\u012bjumus asto\u0146iem medikamentiem. Izmai\u0146as skar kr\u016bts v\u0113\u017ea, Hod\u017ekina limfomas un A hemofilijas \u0101rst\u0113\u0161anu, k\u0101 ar\u012b p\u0101rejas terapiju b\u0113rniem ar spin\u0101lo musku\u013cu atrofiju pirms g\u0113nu terapijas s\u0101k\u0161anas. P\u0101rskat\u012bti ar\u012b nosac\u012bjumi intravenozo dzelzs prepar\u0101tu sa\u0146em\u0161anai gr\u016btniec\u0113m un intravitre\u0101laj\u0101m injekcij\u0101m.<\/p>\n<p>Rug\u0101ja inform\u0113ja, ka par intravitre\u0101laj\u0101m injekcij\u0101m pacientiem ar m\u0101kulas t\u016bsku turpin\u0101s sarunas ar ra\u017eot\u0101jiem. \u0160ogad terapiju pl\u0101nots nodro\u0161in\u0101t 112 pacientiem, kas ir vair\u0101k par s\u0101kotn\u0113ji pl\u0101noto.<\/p>\n<p>Pla\u0161\u0101kam pacientu lokam paredz\u0113ti ar\u012b inovat\u012bvi holester\u012bna l\u012bmeni pazemino\u0161i l\u012bdzek\u013ci. Pacientiem p\u0113c asinsvadu oper\u0101cij\u0101m un manipul\u0101cij\u0101m zema bl\u012bvuma lipoprote\u012bnu holester\u012bna robe\u017ev\u0113rt\u012bba \u0161o z\u0101\u013cu sa\u0146em\u0161anai samazin\u0101ta no 3,0 l\u012bdz 1,8 milimoliem litr\u0101. Vair\u0101kos sirds un asinsvadu slim\u012bbu gad\u012bjumos atcelta pras\u012bba p\u0113c slimn\u012bcas konsilija l\u0113muma un konkr\u0113tas \u0101rstniec\u012bbas iest\u0101des speci\u0101lista noz\u012bm\u0113juma.<\/p>\n<p>Papla\u0161in\u0101ts ar\u012b z\u0101\u013cu izrakst\u012bt\u0101ju loks hroniskas nieru mazsp\u0113jas, vieglo \u0137\u0113\u017eu amiloidozes un atsevi\u0161\u0137os psori\u0101zes \u0101rst\u0113\u0161anas gad\u012bjumos. Savuk\u0101rt gr\u016btniec\u012bbas, dzemd\u012bbu un p\u0113cdzemd\u012bbu period\u0101 kompens\u0101cijas apm\u0113rs palielin\u0101ts no 75% l\u012bdz 100%.<\/p>\n<p>Rug\u0101ja uzsv\u0113ra, ka liela da\u013ca pieejam\u012bbas uzlabojumu pan\u0101kta bez papildu finans\u0113juma &#8211; ar ra\u017eot\u0101ju l\u012bdzdal\u012bbu, cenu p\u0101rrun\u0101m vai iek\u0161\u0113jiem ietaup\u012bjumiem. NVD prezent\u0101cij\u0101 min\u0113ts, ka \u0161o izmai\u0146u kop\u0113jais ieguvums var\u0113tu b\u016bt aptuveni 123 000 pacientu.<\/p>\n<p>T\u0101pat Rug\u0101ja nor\u0101d\u012bja, ka p\u0113c septi\u0146u m\u0113ne\u0161u datiem z\u0101\u013cu kompens\u0101cijas sist\u0113m\u0101 prognoz\u0113jams finan\u0161u iztr\u016bkums. NVD septi\u0146u m\u0113ne\u0161u prognoze liecina 368,95 miljonu eiro izlietojumu z\u0101\u013cu kompens\u0101cijai. P\u0113rn sist\u0113m\u0101 izlietoti 339,48 miljoni eiro, bet 2018. gad\u0101 &#8211; 175,21 miljons eiro. Unik\u0101lo pacientu skaits no 2018. l\u012bdz 2025. gadam palielin\u0101jies no 718 452 l\u012bdz 760 047.<\/p>\n<p>S\u0113d\u0113 jaut\u0101ts ar\u012b par migr\u0113nas \u0101rst\u0113\u0161anai paredz\u0113to z\u0101\u013cu pieejam\u012bbu. Rug\u0101ja skaidroja, ka hroniskas migr\u0113nas pacientiem sa\u0146em\u0161anas nosac\u012bjumi tiek atviegloti pak\u0101peniski, tostarp samazin\u0101ts p\u0113c iepriek\u0161\u0113j\u0101s terapijas nepiecie\u0161amais nov\u0113ro\u0161anas laiks. NVD turpina cenu p\u0101rrunas ar ra\u017eot\u0101jiem un v\u0113rt\u0113, vai z\u0101\u013cu sa\u0146em\u0161anai nepiecie\u0161ams konsilija l\u0113mums. Vi\u0146a uzsv\u0113ra, ka bez papildu finans\u0113juma katra so\u013ca ietekme uz bud\u017eetu r\u016bp\u012bgi j\u0101apr\u0113\u0137ina. Epizodisk\u0101s migr\u0113nas \u0101rst\u0113\u0161ana iek\u013cauta priorit\u0101ro pas\u0101kumu piepras\u012bjumos.<\/p>\n<p>S\u0113d\u0113 izskan\u0113ja, ka iek\u013cau\u0161anu kompens\u0101cijas sist\u0113m\u0101 gaida 124 medikamenti, kas nepiecie\u0161ami aptuveni 13 000 iedz\u012bvot\u0101ju. Tika paustas ba\u017eas, ka bez liel\u0101ka bud\u017eeta pacientu organiz\u0101cij\u0101m ar\u012b turpm\u0101k n\u0101ksies c\u012bn\u012bties par katras terapijas pieejam\u012bbu atsevi\u0161\u0137i.<\/p>\n<p>Vair\u0101ki s\u0113des dal\u012bbnieki uzsv\u0113ra, ka par uzlabojumiem var\u0113s p\u0101rliecin\u0101ties tikai tad, kad pacienti z\u0101les un ier\u012bces patie\u0161\u0101m sa\u0146ems un to apmaksa b\u016bs redzama valsts bud\u017eet\u0101. Diskusij\u0101 izskan\u0113ja ba\u017eas, ka bez vesel\u012bbas apr\u016bpes noteik\u0161anas par politisku priorit\u0101ti finans\u0113juma nepietiks vis\u0101m vajadz\u012bb\u0101m.<\/p>\n<p>Valsts kontroles padomes locekle <strong>Maija \u0100boli\u0146a<\/strong> atz\u012bm\u0113ja, ka pacientu organiz\u0101ciju paust\u0101s ba\u017eas ir pamatotas, nor\u0101dot ar\u012b uz bie\u017eajiem iedz\u012bvot\u0101ju l\u016bgumiem ziedot \u0101rst\u0113\u0161anai nepiecie\u0161amaj\u0101m z\u0101l\u0113m.<\/p>\n<p>K\u0101 zi\u0146ots, ka Vesel\u012bbas ministrija (VM) ir apzin\u0101jusi nozares papildu finans\u0113juma vajadz\u012bbas 663 miljonu eiro apm\u0113r\u0101, bet k\u0101 priorit\u0101ri \u012bstenojamus pas\u0101kumus 2027. gadam noteikusi iniciat\u012bvas 319,5 miljonu eiro apm\u0113r\u0101.<\/p>\n<p>Finans\u0113jums vajadz\u012bgs jaunu terapiju, z\u0101\u013cu un apr\u016bpes inov\u0101ciju pieejam\u012bbai, cilv\u0113kresursu nodro\u0161in\u0101\u0161anai un \u0101rstniec\u012bbas personu atalgojumam.<\/p>\n<p>Liel\u0101k\u0101 summa &#8211; 308,6 miljoni eiro &#8211; b\u016btu nepiecie\u0161ama vesel\u012bbas apr\u016bpes pakalpojumu pieejam\u012bbas un kvalit\u0101tes uzlabo\u0161anai. Finans\u0113jumu paredz\u0113ts izmantot valsts apmaks\u0101to pakalpojumu apjoma palielin\u0101\u0161anai, lai sa\u012bsin\u0101tu gaid\u012b\u0161anas rindas uz speci\u0101listu konsult\u0101cij\u0101m, diagnostiskajiem izmekl\u0113jumiem un pl\u0101nveida oper\u0101cij\u0101m.<\/p>\n<p>L\u012bdzek\u013ci b\u016btu vajadz\u012bgi ar\u012b pakalpojumu tarifu tuvin\u0101\u0161anai faktiskaj\u0101m izmaks\u0101m, lai \u0101rstniec\u012bbas iest\u0101des valsts apmaks\u0101tos pakalpojumus sp\u0113tu sniegt piln\u0101 apm\u0113r\u0101.<\/p>\n<p>Kompens\u0113jamo medikamentu un materi\u0101lu sist\u0113mas uzlabo\u0161anai papildu b\u016btu nepiecie\u0161ami 130,3 miljoni eiro. Tas \u013cautu kompens\u0113jamo z\u0101\u013cu sarakst\u0101 iek\u013caut jaunas, kl\u012bniski efekt\u012bvas z\u0101les, tostarp onkolo\u0123isko, reto slim\u012bbu un diab\u0113ta pacientu \u0101rst\u0113\u0161anai, k\u0101 ar\u012b palielin\u0101t kompens\u0101cijas apm\u0113ru un samazin\u0101t pacientu l\u012bdzmaks\u0101jumus.<\/p>\n<p>Vesel\u012bbas apr\u016bpes politikas \u012bsteno\u0161anai, tostarp onkolo\u0123ijas, m\u0101tes un b\u0113rna vesel\u012bbas, sirds un asinsvadu vesel\u012bbas un reto slim\u012bbu pl\u0101nu pas\u0101kumiem, nepiecie\u0161ami 82,3 miljoni eiro. Cilv\u0113kresursu piesaistei un notur\u0113\u0161anai nozar\u0113, \u0101rstniec\u012bbas personu darba samaksas konkur\u0113tsp\u0113jas uzlabo\u0161anai, rezident\u016bras vietu un medic\u012bnas izgl\u012bt\u012bbas kapacit\u0101tes palielin\u0101\u0161anai vajadz\u012bgi v\u0113l 45,2 miljoni eiro.<\/p>\n<p>\u0100rstniec\u012bbas iest\u0101\u017eu infrastrukt\u016bras un medic\u012bnas tehnolo\u0123iju atjauno\u0161anai nepiecie\u0161ami 25 miljoni eiro, prim\u0101r\u0101s vesel\u012bbas apr\u016bpes stiprin\u0101\u0161anai &#8211; 22,9 miljoni eiro, bet sabiedr\u012bbas vesel\u012bbas un profilakses pas\u0101kumiem &#8211; 21,3 miljoni eiro.<\/p>\n<p>Psihisk\u0101s vesel\u012bbas apr\u016bpei un atkar\u012bbu mazin\u0101\u0161anai papildu nepiecie\u0161ami 12,4 miljoni eiro, VM padot\u012bbas iest\u0101\u017eu priorit\u0101rajiem pas\u0101kumiem &#8211; 10,4 miljoni eiro, bet vesel\u012bbas nozares digitaliz\u0101cijai &#8211; 4,6 miljoni eiro.<\/p>\n<p>Papildu 2027. gad\u0101 3,6 miljoni eiro b\u016btu nepiecie\u0161ami, lai atbilsto\u0161i Saeimas lemtajam nodro\u0161in\u0101tu valsts atbalstu nep\u0101rtraukt\u0101s glikozes l\u012bme\u0146a noteik\u0161anas sensoru un insul\u012bna s\u016bk\u0146u kompens\u0101cijai 1. tipa diab\u0113ta pacientiem.<\/p>\n<p>Avots: LETA<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>No 1. oktobra papla\u0161in\u0101s vair\u0101ku medikamentu kompens\u0101cijas nosac\u012bjumus, tostarp solido audz\u0113ju, spin\u0101l\u0101s musku\u013cu atrofijas un iekais\u012bgu zarnu slim\u012bbu \u0101rst\u0113\u0161anai, otrdien Saeimas Sabiedr\u012bbas vesel\u012bbas apak\u0161komisijas s\u0113d\u0113 inform\u0113ja Nacion\u0101l\u0101 vesel\u012bbas dienesta (NVD) [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":12053,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[76,73],"tags":[12,367],"mic_flag":[],"class_list":["post-22969","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunakie-raksti","category-medikamentu-zinas","tag-nvd","tag-zalu-kompensacija"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"No 1. oktobra papla\u0161in\u0101s vair\u0101ku medikamentu kompens\u0101cijas nosac\u012bjumus, tostarp solido audz\u0113ju, spin\u0101l\u0101s musku\u013cu atrofijas un iekais\u012bgu zarnu slim\u012bbu \u0101rst\u0113\u0161anai, otrdien Saeimas Sabiedr\u012bbas vesel\u012bbas apak\u0161komisijas s\u0113d\u0113 inform\u0113ja Nacion\u0101l\u0101 vesel\u012bbas dienesta (NVD) Z\u0101\u013cu un medic\u012bnisko ier\u012b\u010du departamenta direktora vietniece Zinta Rug\u0101ja. Pacientu organiz\u0101ciju p\u0101rst\u0101vji vienlaikus uzsv\u0113ra, ka daudzas nepiecie\u0161am\u0101s z\u0101les joproj\u0101m nav pieejamas un uzlabojumiem vajadz\u012bgs liel\u0101ks\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"NVD no oktobra papla\u0161in\u0101s kompens\u0113jamo z\u0101\u013cu pieejam\u012bbu vair\u0101ku slim\u012bbu pacientiem - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"No 1. oktobra papla\u0161in\u0101s vair\u0101ku medikamentu kompens\u0101cijas nosac\u012bjumus, tostarp solido audz\u0113ju, spin\u0101l\u0101s musku\u013cu atrofijas un iekais\u012bgu zarnu slim\u012bbu \u0101rst\u0113\u0161anai, otrdien Saeimas Sabiedr\u012bbas vesel\u012bbas apak\u0161komisijas s\u0113d\u0113 inform\u0113ja Nacion\u0101l\u0101 vesel\u012bbas dienesta (NVD) Z\u0101\u013cu un medic\u012bnisko ier\u012b\u010du departamenta direktora vietniece Zinta Rug\u0101ja. Pacientu organiz\u0101ciju p\u0101rst\u0101vji vienlaikus uzsv\u0113ra, ka daudzas nepiecie\u0161am\u0101s z\u0101les joproj\u0101m nav pieejamas un uzlabojumiem vajadz\u012bgs liel\u0101ks\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/tabletes-un-nauda.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/tabletes-un-nauda.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-09-30T06:48:22+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-09-30T06:48:22+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"NVD no oktobra papla\u0161in\u0101s kompens\u0113jamo z\u0101\u013cu pieejam\u012bbu vair\u0101ku slim\u012bbu pacientiem - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"No 1. oktobra papla\u0161in\u0101s vair\u0101ku medikamentu kompens\u0101cijas nosac\u012bjumus, tostarp solido audz\u0113ju, spin\u0101l\u0101s musku\u013cu atrofijas un iekais\u012bgu zarnu slim\u012bbu \u0101rst\u0113\u0161anai, otrdien Saeimas Sabiedr\u012bbas vesel\u012bbas apak\u0161komisijas s\u0113d\u0113 inform\u0113ja Nacion\u0101l\u0101 vesel\u012bbas dienesta (NVD) Z\u0101\u013cu un medic\u012bnisko ier\u012b\u010du departamenta direktora vietniece Zinta Rug\u0101ja. Pacientu organiz\u0101ciju p\u0101rst\u0101vji vienlaikus uzsv\u0113ra, ka daudzas nepiecie\u0161am\u0101s z\u0101les joproj\u0101m nav pieejamas un uzlabojumiem vajadz\u012bgs liel\u0101ks\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/tabletes-un-nauda.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/medikamentu-zinas\\\/#listItem\",\"name\":\"Medikamenti\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/medikamentu-zinas\\\/#listItem\",\"position\":2,\"name\":\"Medikamenti\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/medikamentu-zinas\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\\\/#listItem\",\"name\":\"NVD no oktobra papla\\u0161in\\u0101s kompens\\u0113jamo z\\u0101\\u013cu pieejam\\u012bbu vair\\u0101ku slim\\u012bbu pacientiem\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\\\/#listItem\",\"position\":3,\"name\":\"NVD no oktobra papla\\u0161in\\u0101s kompens\\u0113jamo z\\u0101\\u013cu pieejam\\u012bbu vair\\u0101ku slim\\u012bbu pacientiem\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/medikamentu-zinas\\\/#listItem\",\"name\":\"Medikamenti\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\\\/#newsarticle\",\"name\":\"NVD no oktobra papla\\u0161in\\u0101s kompens\\u0113jamo z\\u0101\\u013cu pieejam\\u012bbu vair\\u0101ku slim\\u012bbu pacientiem - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"NVD no oktobra papla\\u0161in\\u0101s kompens\\u0113jamo z\\u0101\\u013cu pieejam\\u012bbu vair\\u0101ku slim\\u012bbu pacientiem\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/tabletes-un-nauda.jpg\",\"width\":2000,\"height\":1000},\"datePublished\":\"2026-09-30T08:48:22+03:00\",\"dateModified\":\"2026-09-30T08:48:22+03:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\\\/#webpage\"},\"articleSection\":\"Jaun\\u0101kie raksti, Medikamenti, NVD, z\\u0101\\u013cu kompens\\u0101cija\",\"dateline\":\"Published on September 30, 2026.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\\\/\",\"name\":\"NVD no oktobra papla\\u0161in\\u0101s kompens\\u0113jamo z\\u0101\\u013cu pieejam\\u012bbu vair\\u0101ku slim\\u012bbu pacientiem - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"No 1. oktobra papla\\u0161in\\u0101s vair\\u0101ku medikamentu kompens\\u0101cijas nosac\\u012bjumus, tostarp solido audz\\u0113ju, spin\\u0101l\\u0101s musku\\u013cu atrofijas un iekais\\u012bgu zarnu slim\\u012bbu \\u0101rst\\u0113\\u0161anai, otrdien Saeimas Sabiedr\\u012bbas vesel\\u012bbas apak\\u0161komisijas s\\u0113d\\u0113 inform\\u0113ja Nacion\\u0101l\\u0101 vesel\\u012bbas dienesta (NVD) Z\\u0101\\u013cu un medic\\u012bnisko ier\\u012b\\u010du departamenta direktora vietniece Zinta Rug\\u0101ja. Pacientu organiz\\u0101ciju p\\u0101rst\\u0101vji vienlaikus uzsv\\u0113ra, ka daudzas nepiecie\\u0161am\\u0101s z\\u0101les joproj\\u0101m nav pieejamas un uzlabojumiem vajadz\\u012bgs liel\\u0101ks\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/tabletes-un-nauda.jpg\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\\\/#mainImage\",\"width\":2000,\"height\":1000},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\\\/#mainImage\"},\"datePublished\":\"2026-09-30T08:48:22+03:00\",\"dateModified\":\"2026-09-30T08:48:22+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"NVD no oktobra papla\u0161in\u0101s kompens\u0113jamo z\u0101\u013cu pieejam\u012bbu vair\u0101ku slim\u012bbu pacientiem - Medikamentu Inform\u0101cijas Centrs","description":"No 1. oktobra papla\u0161in\u0101s vair\u0101ku medikamentu kompens\u0101cijas nosac\u012bjumus, tostarp solido audz\u0113ju, spin\u0101l\u0101s musku\u013cu atrofijas un iekais\u012bgu zarnu slim\u012bbu \u0101rst\u0113\u0161anai, otrdien Saeimas Sabiedr\u012bbas vesel\u012bbas apak\u0161komisijas s\u0113d\u0113 inform\u0113ja Nacion\u0101l\u0101 vesel\u012bbas dienesta (NVD) Z\u0101\u013cu un medic\u012bnisko ier\u012b\u010du departamenta direktora vietniece Zinta Rug\u0101ja. Pacientu organiz\u0101ciju p\u0101rst\u0101vji vienlaikus uzsv\u0113ra, ka daudzas nepiecie\u0161am\u0101s z\u0101les joproj\u0101m nav pieejamas un uzlabojumiem vajadz\u012bgs liel\u0101ks","canonical_url":"https:\/\/farmacija-mic.lv\/en\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/medikamentu-zinas\/#listItem","name":"Medikamenti"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/medikamentu-zinas\/#listItem","position":2,"name":"Medikamenti","item":"https:\/\/farmacija-mic.lv\/category\/medikamentu-zinas\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/#listItem","name":"NVD no oktobra papla\u0161in\u0101s kompens\u0113jamo z\u0101\u013cu pieejam\u012bbu vair\u0101ku slim\u012bbu pacientiem"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/#listItem","position":3,"name":"NVD no oktobra papla\u0161in\u0101s kompens\u0113jamo z\u0101\u013cu pieejam\u012bbu vair\u0101ku slim\u012bbu pacientiem","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/medikamentu-zinas\/#listItem","name":"Medikamenti"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/#newsarticle","name":"NVD no oktobra papla\u0161in\u0101s kompens\u0113jamo z\u0101\u013cu pieejam\u012bbu vair\u0101ku slim\u012bbu pacientiem - Medikamentu Inform\u0101cijas Centrs","headline":"NVD no oktobra papla\u0161in\u0101s kompens\u0113jamo z\u0101\u013cu pieejam\u012bbu vair\u0101ku slim\u012bbu pacientiem","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/tabletes-un-nauda.jpg","width":2000,"height":1000},"datePublished":"2026-09-30T08:48:22+03:00","dateModified":"2026-09-30T08:48:22+03:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/#webpage"},"articleSection":"Jaun\u0101kie raksti, Medikamenti, NVD, z\u0101\u013cu kompens\u0101cija","dateline":"Published on September 30, 2026."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/","name":"NVD no oktobra papla\u0161in\u0101s kompens\u0113jamo z\u0101\u013cu pieejam\u012bbu vair\u0101ku slim\u012bbu pacientiem - Medikamentu Inform\u0101cijas Centrs","description":"No 1. oktobra papla\u0161in\u0101s vair\u0101ku medikamentu kompens\u0101cijas nosac\u012bjumus, tostarp solido audz\u0113ju, spin\u0101l\u0101s musku\u013cu atrofijas un iekais\u012bgu zarnu slim\u012bbu \u0101rst\u0113\u0161anai, otrdien Saeimas Sabiedr\u012bbas vesel\u012bbas apak\u0161komisijas s\u0113d\u0113 inform\u0113ja Nacion\u0101l\u0101 vesel\u012bbas dienesta (NVD) Z\u0101\u013cu un medic\u012bnisko ier\u012b\u010du departamenta direktora vietniece Zinta Rug\u0101ja. Pacientu organiz\u0101ciju p\u0101rst\u0101vji vienlaikus uzsv\u0113ra, ka daudzas nepiecie\u0161am\u0101s z\u0101les joproj\u0101m nav pieejamas un uzlabojumiem vajadz\u012bgs liel\u0101ks","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/tabletes-un-nauda.jpg","@id":"https:\/\/farmacija-mic.lv\/en\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/#mainImage","width":2000,"height":1000},"primaryImageOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/#mainImage"},"datePublished":"2026-09-30T08:48:22+03:00","dateModified":"2026-09-30T08:48:22+03:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"NVD no oktobra papla\u0161in\u0101s kompens\u0113jamo z\u0101\u013cu pieejam\u012bbu vair\u0101ku slim\u012bbu pacientiem - Medikamentu Inform\u0101cijas Centrs","og:description":"No 1. oktobra papla\u0161in\u0101s vair\u0101ku medikamentu kompens\u0101cijas nosac\u012bjumus, tostarp solido audz\u0113ju, spin\u0101l\u0101s musku\u013cu atrofijas un iekais\u012bgu zarnu slim\u012bbu \u0101rst\u0113\u0161anai, otrdien Saeimas Sabiedr\u012bbas vesel\u012bbas apak\u0161komisijas s\u0113d\u0113 inform\u0113ja Nacion\u0101l\u0101 vesel\u012bbas dienesta (NVD) Z\u0101\u013cu un medic\u012bnisko ier\u012b\u010du departamenta direktora vietniece Zinta Rug\u0101ja. Pacientu organiz\u0101ciju p\u0101rst\u0101vji vienlaikus uzsv\u0113ra, ka daudzas nepiecie\u0161am\u0101s z\u0101les joproj\u0101m nav pieejamas un uzlabojumiem vajadz\u012bgs liel\u0101ks","og:url":"https:\/\/farmacija-mic.lv\/en\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/","og:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/tabletes-un-nauda.jpg","og:image:secure_url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/tabletes-un-nauda.jpg","og:image:width":2000,"og:image:height":1000,"article:published_time":"2026-09-30T06:48:22+00:00","article:modified_time":"2026-09-30T06:48:22+00:00","twitter:card":"summary_large_image","twitter:title":"NVD no oktobra papla\u0161in\u0101s kompens\u0113jamo z\u0101\u013cu pieejam\u012bbu vair\u0101ku slim\u012bbu pacientiem - Medikamentu Inform\u0101cijas Centrs","twitter:description":"No 1. oktobra papla\u0161in\u0101s vair\u0101ku medikamentu kompens\u0101cijas nosac\u012bjumus, tostarp solido audz\u0113ju, spin\u0101l\u0101s musku\u013cu atrofijas un iekais\u012bgu zarnu slim\u012bbu \u0101rst\u0113\u0161anai, otrdien Saeimas Sabiedr\u012bbas vesel\u012bbas apak\u0161komisijas s\u0113d\u0113 inform\u0113ja Nacion\u0101l\u0101 vesel\u012bbas dienesta (NVD) Z\u0101\u013cu un medic\u012bnisko ier\u012b\u010du departamenta direktora vietniece Zinta Rug\u0101ja. Pacientu organiz\u0101ciju p\u0101rst\u0101vji vienlaikus uzsv\u0113ra, ka daudzas nepiecie\u0161am\u0101s z\u0101les joproj\u0101m nav pieejamas un uzlabojumiem vajadz\u012bgs liel\u0101ks","twitter:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/tabletes-un-nauda.jpg"},"aioseo_meta_data":{"post_id":"22969","title":null,"description":null,"keywords":null,"keyphrases":{"focus":[],"additional":[]},"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-10-16 21:05:03","updated":"2026-10-30 10:46:26"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/medikamentu-zinas\/\" title=\"Medikamenti\">Medikamenti<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tNVD no oktobra papla\u0161in\u0101s kompens\u0113jamo z\u0101\u013cu pieejam\u012bbu vair\u0101ku slim\u012bbu pacientiem\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"Medikamenti","link":"https:\/\/farmacija-mic.lv\/category\/medikamentu-zinas\/"},{"label":"NVD no oktobra papla\u0161in\u0101s kompens\u0113jamo z\u0101\u013cu pieejam\u012bbu vair\u0101ku slim\u012bbu pacientiem","link":"https:\/\/farmacija-mic.lv\/en\/nvd-no-oktobra-paplasinas-kompensejamo-zalu-pieejamibu-vairaku-slimibu-pacientiem\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/22969","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=22969"}],"version-history":[{"count":0,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/22969\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media\/12053"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=22969"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=22969"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=22969"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=22969"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}